Digestives & Intestinal Remedies - Hungary

  • Hungary
  • In Hungary, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$9.87m.
  • It is projected that the market will experience an annual growth rate of 3.18% (CAGR 2024-2029).
  • Comparing globally, in China generates the highest revenue in this market, with US$4,408.00m in 2024.
  • When considering the total population, per person revenues of US$0.99 are generated in Hungary in 2024.
  • In Hungary, there is a growing demand for natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Hungary has been experiencing significant growth in recent years. Customer preferences have shifted towards natural and herbal remedies, leading to an increase in demand for digestive and intestinal products that are made from natural ingredients. Additionally, there has been a growing awareness among consumers about the importance of maintaining a healthy gut, which has further fueled the demand for these products.

Customer preferences:
Hungarian consumers are increasingly seeking natural and herbal remedies for digestive and intestinal issues. They are looking for products that are free from artificial additives and chemicals, and instead, contain plant-based ingredients that promote digestive health. This shift in consumer preferences can be attributed to the rising awareness about the potential side effects of conventional medications and the desire for more sustainable and eco-friendly options.

Trends in the market:
One of the major trends in the Digestives & Intestinal Remedies market in Hungary is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for gut health. They help restore the natural balance of bacteria in the digestive tract and improve overall gut function. The demand for probiotic supplements and foods has been on the rise as consumers recognize the importance of maintaining a healthy gut microbiome. This trend is expected to continue driving the growth of the market in the coming years.Another trend in the market is the increasing availability of digestive and intestinal remedies in various forms such as capsules, tablets, powders, and liquids. This allows consumers to choose the format that is most convenient for them and aligns with their individual preferences. For example, some consumers may prefer taking a daily probiotic capsule, while others may prefer a powdered form that can be easily mixed into their favorite beverage.

Local special circumstances:
Hungary has a rich tradition of herbal medicine and natural remedies. The use of herbs and natural ingredients for medicinal purposes has been deeply ingrained in the culture. This cultural background has contributed to the growing demand for natural and herbal digestive and intestinal remedies in the country. Consumers in Hungary are more likely to trust and rely on traditional remedies that have been used for generations.

Underlying macroeconomic factors:
The growing Digestives & Intestinal Remedies market in Hungary can also be attributed to the overall economic development of the country. As disposable incomes have increased, consumers are more willing to spend on health and wellness products. The rising middle class in Hungary has become more health-conscious and is willing to invest in products that promote their well-being. This has created a favorable market environment for the Digestives & Intestinal Remedies industry to thrive.In conclusion, the Digestives & Intestinal Remedies market in Hungary is witnessing growth due to the shift in customer preferences towards natural and herbal remedies, the rising popularity of probiotics, the availability of remedies in various forms, the cultural inclination towards traditional remedies, and the overall economic development of the country. These factors are expected to continue driving the growth of the market in the foreseeable future.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)